GMAB Stock Valuation & Analysis

Stock Screener

Valuator

Education

Pricing

Community

Home

Stock Screener

Valuator

Education

Pricing

Community

Genmab A/S

NASDAQ

GMAB

Last Price

US $32.84

KEY FIGURES

MKT CAP

$20.2B

EPS

TTM

$1.29

EPS Growth (1Y)

-87.31%

PEG

TTM

P/E

TTM

25.46x

P/S

TTM

2.09x

YIELD

GROWTH (5Y CAGR)

Performance & Financial Health

Profit margin

Current Ratio

Capital Returns

13.58%

Return on equity

ROIC: 9.91%

Valuation History

24.4X

Price to Earnings

EV/EBITDA: 17.2X

Cash flow

Profit margin

Institutional-grade investment tools for everyone. Built in Sweden. Trusted by investors worldwide.

Platform

Stock Screener

Valuator

Investment Score

Community

Education

Company

About

Pricing

Contact

Legal

Cookie Policy

Genmab A/S

NASDAQ

GMAB

Last Price

US $32.84

KEY FIGURES

MKT CAP

$20.2B

EPS

TTM

$1.29

EPS Growth (1Y)

-87.31%

PEG

TTM

P/E

TTM

25.46x

P/S

TTM

2.09x

YIELD

GROWTH (5Y CAGR)

Performance & Financial Health

Profit margin

Current Ratio

Capital Returns

13.58%

Return on equity

ROIC: 9.91%

Valuation History

24.4X

Price to Earnings

EV/EBITDA: 17.2X

Cash flow

Profit margin

Base valuations

Cash Flow (DCF)

Fair Value

N/A

Market $32.84

—

Default assumptions

EBITDA Multiple

Fair Value

$8.99

Market $32.84

-72.62%

Default assumptions

EARNINGS FV

Fair Value

$12.92

Market $32.84

-60.66%

Default assumptions

Base valuations use default assumptions. Customize in the Valuator.